Scientists have taken a major step toward protecting the very cells that make sharp, colorful vision possible. By testing ...
A Mount Sinai ophthalmologist will unveil a novel surgical technology that allows eye surgeons to measure and respond to ...
Major ophthalmic events in the first quarter of 2026 included treatments for presbyopia, age-related macular degeneration ...
Maria Grant, M.D., FARVO, professor and Eivor and Alston Callahan, M.D., Endowed Chair in Ophthalmology, continues to shape the future of retinal disease research through her pioneering contributions ...
Please provide your email address to receive an email when new articles are posted on . Price said pharmaceuticals are under study for neurotrophic keratitis, nonhealing epithelial defects and limbal ...
PRIME designation follows recent Breakthrough Therapy designation from the U.S. FDA, underscoring the importance and urgency of addressing optic neuritis, a serious condition that can have negative ...
ZUG, Switzerland, 16 March, 2026 -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (Oculis), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results